RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. D/E ratio (%)

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndD/E ratio (%) (Million USD)YoY (%)
Jun 30, 202511-23.05%
Jun 30, 202414.3-58.63%
Jun 30, 202334.7+52.18%
Jun 30, 202222.8+2.14%
Jun 30, 202122.3-52.18%
Jun 30, 202046.6-23.26%
Jun 30, 201960.8+363.29%
Jun 30, 201813.1-76.17%
Jun 30, 201755+6.78%
Jun 30, 201651.5+172.10%
Jun 30, 201518.9+10.70%
Jun 30, 201417.1-8.40%
Jun 30, 201318.7+19.70%
Jun 30, 201215.6+169.60%
Jun 30, 20115.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)